Expert Perspectives on the Utility of Real-World Data in the Management of Plaque Psoriasis - Episode 15

Plaque Psoriasis: Future Therapeutic Pipeline

, ,

Brad Glick, DO, AOCD, George Han, MD, PhD, and Neal Bhatia, MD, look to the future at what is upcoming in the treatment pipeline for plaque psoriasis treatment.

EP. 1: Plaque Psoriasis: Current Expansion of the Therapeutic Landscape
EP. 2: Shifting Treatment Approaches to Plaque Psoriasis
EP. 3: Current Role of Topical Therapy for Plaque Psoriasis Treatment
EP. 4: Spectrum of Disease and Current Treatment Options for Plaque Psoriasis
EP. 5: Plaque Psoriasis: Escalating Treatment
EP. 6: Communication With Patients About Plaque Psoriasis Treatment
EP. 7: IL-23 inhibitors for Plaque Psoriasis Treatment
EP. 8: Impact of Treatment Mode of Delivery on Patient Adherence and Plaque Psoriasis Treatment Selection
EP. 9: Long-Term Persistence of Biologic Treatment Options for Plaque Psoriasis
EP. 10: IL-23 Inhibitors and the Current Treatment Landscape for Plaque Psoriasis
EP. 11: Long Term Efficacy And Safety Data: IL-23 Inhibitors in Patients with Moderate to Severe Plaque Psoriasis
EP. 12: BMI and Background Comorbidities that Impact Plaque Psoriasis Treatment
EP. 13: Plaque Psoriasis: Older Populations and Skin of Color
EP. 14: Looking Ahead at Clinical Trial Metrics for Plaque Psoriasis
Now Viewing
EP. 15: Plaque Psoriasis: Future Therapeutic Pipeline